|
Biochemical Pharmacology Discussion Group
The Biochemical Pharmacology Discussion Group represents a diverse group of scientists from pharmaceutical and biotechnology companies and university and medical research centers interested in biochemistry, molecular biology, biomedical research, and related areas. The group brings together diverse institutions and communities, industrial and academic, to share new and relevant information at the frontiers of research and development. The group also serves as the Biochemical Topical Group for the American Chemical Society's New York Section.
Events
Tuesday, February 23, 2010 | 1:00 PM - 5:00 PM
Speakers: Mark Bear (Massachusetts Institute of Technology), Bita Moghaddam (University of Pittsburgh), Colleen Niswender (Vanderbilt University School of Medicine), Jean-Philippe Pin (Université de Montpellier) and Jean-Philippe Rocher (Addex Pharmaceuticals)
This symposium will include detailed discussions of these unique GPCRs, considered by many to be the single most promising new collection of targets for CNS drug discovery.
Tuesday, March 23, 2010 | 1:00 PM - 5:00 PM
Speakers: John Hambor (Cell Therapy Group), Konrad Hochedlinger (Harvard Stem Cell Institute), and Timothy Kamp (University of Wisconsin)
Induced pluripotent stem cells could maintain the potential of embryonic stem cells without using embryos. This symposium will cover the current and potential use of pluripotent stem cells to enable technology in drug discovery and therapeutics.
Tuesday, April 27, 2010 | 9:00 AM - 5:00 PM
Organizers: Chad E. Beyer (University of Colorado School of Medicine), Mark R. Bowlby (Merck Research Labs) and Jennifer Henry (The New York Academy of Sciences)
This symposium addresses clinical applications and new pain mechanisms for the treatment of chronic pain syndromes, and provides an update on the progress and barriers to developing effective preclinical models of pain, in particular fibromyalgia.
Steering Committee
Ildiko Antal, PhD
Wyeth Research
|
Lakshmi Devi
Mount Sinai Medical School
|
Ahmad Fawzi, PhD
Acucela, Inc.
|
Carolyn Foster, PhD
Boehringer Ingelheim
|
|
Cochair
Weill Medical College, Cornell University
|
John E. Hambor, PhD
Cognate BioServices
|
Julia Heinrich, PhD
|
Huiping Jiang, PhD
Boehringer Ingelheim
|
Kenneth Jones, PhD
Lundbeck
|
Janet Kerr, PhD
Merck Research Laboratories
|
Kenneth LaMontagne, PhD
Novartis
|
Charles A. Lunn, PhD
Program Coordinator
Schering-Plough Research Institute
|
Jose R. Perez, PhD
Cochair
Broad Institute
|
Barbara Petrack, PhD
Drew University
|
Esther Sabban, PhD
New York Medical College
|
Pallavi Sachdev
Rockefeller University
|
JoAnne Saye, PhD
AstraZeneca
|
June Sonnenberg, PhD
Secretary
Wyeth
|
W. Ross Tracey, PhD
Novartis Institutes for BioMedical Research
|
Lawrence Wennogle, PhD
Intra-Cellular Therapies Inc.
|
George Zavoico, PhD
Westport Capital Markets, LLC
|
|
Sponsors
Mission Partner support for the Frontiers of Science program provided by:
Get more information about how you can sponsor a discussion group.
|
|